IGC Pharma - Nilai bisnis marang pendapatan IGC

India Globalization Capital (IGC) - logo korporat

IGC Pharma, Inc. (IGC) demonstrates expansion potential by developing therapies for neurodegenerative pathologies. The company's EV/Sales ratio visualizes liquidity dynamics, where the value 17404.76 captures this metric. The issuer's revenues rely on the commercial launch of cannabinoid-based treatments for Alzheimer's. However, geopolitical tensions and sanctions complicate the cross-border logistics of biomaterials, blocking the execution of critical international clinical trials.

IGC Rasio nilai perusahaan marang pendapatan IGC Pharma (23.11.2025 - 20.11.2026)

IGC Pharma, Inc. - rincian analitis lan metrik utama (IGC)

Produk asil prodhuksi IGC Pharma Inc

For IGC Pharma, Inc. (IGC), which remains in a pre-commercial stage with liquidity deficit risks due to prolonged trials, the enterprise value-to-revenue multiple serves as an indicator of market confidence in future assets. This metric compares the total enterprise value (EV), combining market capitalization and net debt, with annual turnover, allowing for an assessment of the real price of the trade flow regardless of debt load and equity issuances.